1. Home
  2. NATL vs MYGN Comparison

NATL vs MYGN Comparison

Compare NATL & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NATL
  • MYGN
  • Stock Information
  • Founded
  • NATL 2023
  • MYGN 1991
  • Country
  • NATL United States
  • MYGN United States
  • Employees
  • NATL N/A
  • MYGN N/A
  • Industry
  • NATL
  • MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • NATL
  • MYGN Health Care
  • Exchange
  • NATL Nasdaq
  • MYGN Nasdaq
  • Market Cap
  • NATL 1.8B
  • MYGN 744.7M
  • IPO Year
  • NATL N/A
  • MYGN 1995
  • Fundamental
  • Price
  • NATL $28.90
  • MYGN $5.63
  • Analyst Decision
  • NATL Buy
  • MYGN Hold
  • Analyst Count
  • NATL 4
  • MYGN 15
  • Target Price
  • NATL $38.75
  • MYGN $15.14
  • AVG Volume (30 Days)
  • NATL 424.3K
  • MYGN 1.7M
  • Earning Date
  • NATL 08-12-2025
  • MYGN 08-05-2025
  • Dividend Yield
  • NATL N/A
  • MYGN N/A
  • EPS Growth
  • NATL N/A
  • MYGN N/A
  • EPS
  • NATL 1.55
  • MYGN N/A
  • Revenue
  • NATL $4,247,000,000.00
  • MYGN $831,300,000.00
  • Revenue This Year
  • NATL $1.81
  • MYGN N/A
  • Revenue Next Year
  • NATL $4.37
  • MYGN $6.68
  • P/E Ratio
  • NATL $18.59
  • MYGN N/A
  • Revenue Growth
  • NATL N/A
  • MYGN 7.38
  • 52 Week Low
  • NATL $22.30
  • MYGN $3.81
  • 52 Week High
  • NATL $35.50
  • MYGN $29.30
  • Technical
  • Relative Strength Index (RSI)
  • NATL 55.79
  • MYGN 60.69
  • Support Level
  • NATL $28.19
  • MYGN $4.90
  • Resistance Level
  • NATL $30.78
  • MYGN $5.74
  • Average True Range (ATR)
  • NATL 0.88
  • MYGN 0.27
  • MACD
  • NATL 0.06
  • MYGN 0.11
  • Stochastic Oscillator
  • NATL 52.76
  • MYGN 88.78

About NATL NCR Atleos Corporation

NCR Atleos Corp is financial technology company providing self-directed banking solutions to a customer base including financial institutions, merchants, manufacturers, retailers and consumers. Self-directed banking is a rapidly growing, secular trend that allows banking customers to transact seamlessly between various channels all for the same transaction. Their comprehensive solutions enable the acceleration of self-directed banking through ATM and interactive teller machine (ITM) technology, including software, services, hardware and its proprietary Allpoint network. Atleos manage its operations in the following segments which includes Self-Service Banking, Network, and Telecommunications abd Technology.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.

Share on Social Networks: